AIG
GEVA

American International Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

American International Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-13,465
Closed -$1.31M – 5292
2015
Q1 		$1.31M Hold
13,465
– – 0.01% 1421
2014
Q4 		$1.25M Sell
13,465
-533
-4% -$42.1K 0.01% 1406
2014
Q3 		$963K Sell
13,998
-10
-0.1% -$716 ﹤0.01% 1594
2014
Q2 		$1.47M Buy
14,008
+931
+7% +$79.2K 0.01% 1301
2014
Q1 		$1.08M Buy
13,077
+314
+2% +$29K 0.01% 1462
2013
Q4 		$826K Buy
12,763
+1,299
+11% +$77.1K ﹤0.01% 1611
2013
Q3 		$726K Buy
11,464
+3,699
+48% +$182K ﹤0.01% 1674
2013
Q2 		$326K Buy
+7,765
New +$354K ﹤0.01% 2167

American International Group's GEVA Position: Q2 2015 in Review

American International Group sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 13,465 shares — an estimated $1.31M sold.

American International Group first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.47M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • American International Group reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • American International Group sold 13,465 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $1.31M.
  • American International Group first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • American International Group's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.47M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on American International Group's 13F filing for Q2 2015, filed 12 Aug 2015.